These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34920756)

  • 1. Adult-onset mast cell activation syndrome following scombroid poisoning: a case report and review of the literature.
    Brock I; Eng N; Maitland A
    J Med Case Rep; 2021 Dec; 15(1):620. PubMed ID: 34920756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium.
    Valent P; Hartmann K; Bonadonna P; Gülen T; Brockow K; Alvarez-Twose I; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Butterfield JH; Lyons JJ; Sperr WR; Greiner G; Sotlar K; Kluin-Nelemans HC; Schwaab J; Lange M; George TI; Siebenhaar F; Broesby-Olsen S; Jawhar M; Nedoszytko B; Castells M; Orfao A; Gotlib J; Reiter A; Horny HP; Triggiani M; Arock M; Metcalfe DD; Akin C
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1941-1950. PubMed ID: 35623575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
    Zaghmout T; Maclachlan L; Bedi N; Gülen T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
    Thomas EG; Thomas DJ
    Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress of mast cell activation syndrome].
    Ren HL; Yang YS; Sun JL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1513-1517. PubMed ID: 34963253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.
    Jackson CW; Pratt CM; Rupprecht CP; Pattanaik D; Krishnaswamy G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview.
    Matito A; Escribese MM; Longo N; Mayorga C; Luengo-Sánchez O; Pérez-Gordo M; Matheu V; Labrador-Horrillo M; Pascal M; Seoane-Reula ME;
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):461-470. PubMed ID: 33541851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell mediators in allergic inflammation and mastocytosis.
    Castells M
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.
    Valent P; Hartmann K; Bonadonna P; Niedoszytko M; Triggiani M; Arock M; Brockow K
    Int Arch Allergy Immunol; 2022; 183(7):693-705. PubMed ID: 35605594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
    Theoharides TC; Tsilioni I; Ren H
    Expert Rev Clin Immunol; 2019 Jun; 15(6):639-656. PubMed ID: 30884251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
    Butterfield JH
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
    Hamilton MJ
    Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast Cell Activation Syndrome.
    Frieri M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation syndrome: a review.
    Frieri M; Patel R; Celestin J
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):27-32. PubMed ID: 23179866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical diagnosis of systemic mast cell disorders.
    Roberts LJ; Oates JA
    J Invest Dermatol; 1991 Mar; 96(3):19S-24S; discussion 24S-25S. PubMed ID: 2002247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
    Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
    Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells signal their importance in health and disease.
    Olivera A; Beaven MA; Metcalfe DD
    J Allergy Clin Immunol; 2018 Aug; 142(2):381-393. PubMed ID: 29454835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scombroid poisoning. A report of seven cases involving the Western Australian salmon, Arripis truttaceus.
    Smart DR
    Med J Aust; 1992 Dec 7-21; 157(11-12):748-51. PubMed ID: 1453998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.